Literature DB >> 7930701

Gentamicin-resistant menadione and hemin auxotrophic Staphylococcus aureus persist within cultured endothelial cells.

J M Balwit1, P van Langevelde, J M Vann, R A Proctor.   

Abstract

Staphylococcus aureus menadione and hemin auxotrophs, generated by in vitro gentamicin selection, demonstrated reduced hemolytic activity and enhanced intracellular survival within cultured bovine aortic endothelial cells relative to their hemolytic parent. Supplementation of the auxotrophs with exogenous menadione or hemin resulted in rapid growth, increased hemolytic activity, and reduced intracellular persistence to the level found for the hemolytic clinical parent. Aminoglycoside selection of staphylococcal menadione and hemin auxotrophs and subsequent persistence of these variants in the intracellular milieu may adapt S. aureus for evasion of host defenses and resistance to antimicrobial therapy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7930701     DOI: 10.1093/infdis/170.4.1033

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  91 in total

Review 1.  Pathophysiology of chronic bacterial osteomyelitis. Why do antibiotics fail so often?

Authors:  J Ciampolini; K G Harding
Journal:  Postgrad Med J       Date:  2000-08       Impact factor: 2.401

2.  Phagolysosomal integrity is generally maintained after Staphylococcus aureus invasion of nonprofessional phagocytes but is modulated by strain 6850.

Authors:  Thiên-Trí Lâm; Bernd Giese; Deepak Chikkaballi; Anika Kühn; Wanja Wolber; Jan Pané-Farré; Daniel Schäfer; Susanne Engelmann; Martin Fraunholz; Bhanu Sinha
Journal:  Infect Immun       Date:  2010-06-07       Impact factor: 3.441

3.  Staphylococcus aureus, Platelets, and the Heart.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.725

4.  Thymidine auxotrophic Staphylococcus aureus small-colony variant endocarditis and left ventricular assist device infection.

Authors:  Awele Maduka-Ezeh; Maria Teresa Seville; Shimon Kusne; Holenarasipur R Vikram; Janis E Blair; Kerryl Greenwood-Quaintance; Francisco Arabia; Robin Patel
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

5.  Diversity in antistaphylococcal mechanisms among membrane-targeting antimicrobial peptides.

Authors:  S P Koo; A S Bayer; M R Yeaman
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

6.  Contribution of Catalase and Superoxide Dismutase to the Intracellular Survival of Clinical Isolates of Staphylococcus aureus in Murine Macrophages.

Authors:  Debaditya Das; Biswadev Bishayi
Journal:  Indian J Microbiol       Date:  2011-01-25       Impact factor: 2.461

7.  sigmaB activity in a Staphylococcus aureus hemB mutant.

Authors:  Maria M Senn; Markus Bischoff; Christof von Eiff; Brigitte Berger-Bächi
Journal:  J Bacteriol       Date:  2005-11       Impact factor: 3.490

8.  Enhanced post-stationary-phase survival of a clinical thymidine-dependent small-colony variant of Staphylococcus aureus results from lack of a functional tricarboxylic acid cycle.

Authors:  Indranil Chatterjee; Mathias Herrmann; Richard A Proctor; Georg Peters; Barbara C Kahl
Journal:  J Bacteriol       Date:  2007-01-26       Impact factor: 3.490

9.  Two diarylurea electron transport inhibitors reduce Staphylococcus aureus hemolytic activity and protect cultured endothelial cells from lysis.

Authors:  R A Proctor; S C Dalal; B Kahl; D Brar; G Peters; W W Nichols
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

10.  Increased expression of clumping factor and fibronectin-binding proteins by hemB mutants of Staphylococcus aureus expressing small colony variant phenotypes.

Authors:  Pierre Vaudaux; Patrice Francois; Carmelo Bisognano; William L Kelley; Daniel P Lew; Jacques Schrenzel; Richard A Proctor; Peter J McNamara; G Peters; Christof Von Eiff
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.